Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ion channels modulating intestinal chloride secretion are a coordinated group of transmembrane proteins in the intestinal epithelium that facilitate the movement of chloride ions into the gut lumen, a process that serves as the primary driver for fluid secretion (Barrett & Keely, 2000). The key apical channels involved are the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Calcium-activated Chloride Channels (CaCCs), such as Anoctamin-1 (TMEM16A), while the Chloride Channel 2 (ClC-2) also contributes to luminal hydration (Field, 2003; Cuppoletti et al., 2004). These channels work in concert with basolateral proteins, including the NKCC1 transporter and potassium channels like KCa3.1 and KCNQ1, which maintain the electrochemical driving force for chloride exit (Thiagarajah & Verkman, 2013). Dysregulation of this system is central to various gastrointestinal pathologies; for instance, overactivation by bacterial toxins leads to life-threatening secretory diarrhea, whereas mutations in CFTR cause the impaired secretion characteristic of cystic fibrosis. Pharmacological agents target these channels to manage bowel disorders, with inhibitors like Crofelemer used to treat diarrhea and activators like Lubiprostone used for chronic constipation (Tradtrantip et al., 2010). Additionally, indirect modulation via upstream signaling pathways, such as the activation of the Guanylate Cyclase-C (GC-C) receptor by Linaclotide, is a common clinical approach to enhance chloride secretion and alleviate constipation-related symptoms.
Regulation of chloride ion efflux across the apical membrane of intestinal epithelial cells to control fluid secretion and luminal hydration.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ion channels modulating intestinal chloride secretion.